Nxera Pharma Co Ltd (SOLTF)
9.72
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
Nxera Pharma Max Drawdown (5Y): 95.29% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 95.29% |
| February 29, 2024 | 95.29% |
| January 31, 2024 | 95.29% |
| December 31, 2023 | 95.29% |
| November 30, 2023 | 95.86% |
| October 31, 2023 | 95.86% |
| September 30, 2023 | 95.86% |
| August 31, 2023 | 96.61% |
| July 31, 2023 | 96.61% |
| June 30, 2023 | 96.61% |
| May 31, 2023 | 96.61% |
| April 30, 2023 | 96.61% |
| March 31, 2023 | 96.61% |
| February 28, 2023 | 96.61% |
| January 31, 2023 | 96.61% |
| December 31, 2022 | 96.61% |
| November 30, 2022 | 96.61% |
| October 31, 2022 | 96.61% |
| September 30, 2022 | 96.61% |
| August 31, 2022 | 96.61% |
| July 31, 2022 | 96.61% |
| June 30, 2022 | 96.61% |
| May 31, 2022 | 96.61% |
| April 30, 2022 | 96.61% |
| March 31, 2022 | 96.61% |
| Date | Value |
|---|---|
| February 28, 2022 | 96.61% |
| January 31, 2022 | 96.61% |
| December 31, 2021 | 96.61% |
| November 30, 2021 | 96.61% |
| October 31, 2021 | 96.61% |
| September 30, 2021 | 96.61% |
| August 31, 2021 | 96.61% |
| July 31, 2021 | 96.61% |
| June 30, 2021 | 96.61% |
| May 31, 2021 | 96.61% |
| April 30, 2021 | 96.61% |
| March 31, 2021 | 96.61% |
| February 28, 2021 | 96.61% |
| January 31, 2021 | 96.61% |
| December 31, 2020 | 96.61% |
| November 30, 2020 | 96.61% |
| October 31, 2020 | 96.61% |
| September 30, 2020 | 96.61% |
| August 31, 2020 | 96.61% |
| July 31, 2020 | 96.61% |
| June 30, 2020 | 96.61% |
| May 31, 2020 | 96.61% |
| April 30, 2020 | 96.61% |
| March 31, 2020 | 96.61% |
| February 29, 2020 | 96.61% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.29%
Minimum
Dec 2023
96.61%
Maximum
Apr 2019
96.49%
Average
96.61%
Median
Apr 2019
Max Drawdown (5Y) Benchmarks
| Takeda Pharmaceutical Co Ltd | 54.24% |
| PeptiDream Inc | 87.73% |
| Stemcell Holdings Inc | -- |
| Healios KK | -- |
| AnGes Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -3.519 |
| Beta (5Y) | 0.0101 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 59.00% |
| Historical Sharpe Ratio (5Y) | -0.0574 |
| Historical Sortino (5Y) | -0.0869 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.70% |